Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Cancer Therapeutics|November 7, 2013
Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancerBrian Y Lee, Falko Hochgräfe, Hui-Ming Lin, et al.
Breast Cancer Research : BCR|December 10, 2025
Modelling the metastatic immune microenvironment in triple-negative breast cancerLaura Rodriguez de la Fuente, Andrew M K Law, Laura Rangel-Sanchez, et al.
Obesity (Silver Spring, Md.)|May 7, 2011
Peripheral-specific y2 receptor knockdown protects mice from high-fat diet-induced obesityYan-Chuan Shi, Shu Lin, Lesley Castillo, et al.
Neuropeptides|October 16, 2012
The endogenous opioid dynorphin is required for normal bone homeostasis in micePaul A Baldock, Frank Driessler, Shu Lin, et al.
Scientific Reports|November 18, 2017
Andy's Algorithms: new automated digital image analysis pipelines for FIJIAndrew M K Law, Julia X M Yin, Lesley Castillo, et al.
Scientific Reports|May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancerHui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
The Prostate|January 10, 2018
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancerHui-Ming Lin, Brian Y Lee, Lesley Castillo, et al.
Plos One|July 9, 2010
NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in miceYan-Chuan Shi, Shu Lin, Iris P L Wong, et al.
Oncogene|November 19, 2019
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinomaLesley Castillo, Adelaide I J Young, Amanda Mawson, et al.
Breast Cancer Research : BCR|December 10, 2016
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinibAdelaide I J Young, Andrew M K Law, Lesley Castillo, et al.
Pageof 2